Form 4: Phathom Pharmaceuticals Director Asit Parikh Acquires 10,000 Shares

Director Asit Parikh of Phathom Pharmaceuticals purchased 10,000 shares of common stock at a weighted average price of $8.1248 on December 13, 2024.

Summary

• Asit Parikh, a director at Phathom Pharmaceuticals, acquired 10,000 shares of the company's common stock on December 13, 2024.
• The shares were purchased at a weighted average price of $8.1248 per share.
• The transactions occurred at prices ranging from $7.9999 to $8.2496.
• Following this transaction, Mr. Parikh directly owns 75,500 shares of Phathom Pharmaceuticals common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. Insider buying can be a positive signal, but this is a routine transaction and not a large amount.

Positives

• The purchase of shares by a director can be seen as a positive sign of confidence in the company's future prospects.

Industry Context

This is a routine filing related to insider trading activity and is common for publicly traded companies. It does not indicate any specific trend in the pharmaceutical industry.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, and this filing is consistent with those requirements.
• The transaction is a relatively small purchase by a director and is not unusual compared to similar filings from other companies.

Stakeholder Impact

• The purchase of shares by a director may have a slightly positive impact on shareholder confidence.

Key Dates

Keywords

Phathom Pharmaceuticals, insider trading, stock purchase, Asit Parikh, director, common stock, share acquisition